Soluble ST2 is associated with postoperative atrial fibrillation after cardiac surgery in postmenopausal women

Andreas Hammer1, Frieda Marka1, Ulrike Baumer2

  • 1Division of Cardiology, Dept. of Internal Medicine II. Medical University of Vienna, Austria; Ludwig Boltzmann Institute for Cardiovascular Research, Vienna, Austria.

Insights

Soluble ST2 (sST2) predicts postoperative atrial fibrillation (POAF) in women undergoing cardiac surgery. Higher sST2 levels correlate with longer POAF duration, suggesting its utility in risk stratification.

Area of Science:

  • Cardiology
  • Biomarkers
  • Cardiac Surgery

Background:

  • Postoperative atrial fibrillation (POAF) is a common cardiac surgery complication.
  • A significant portion of POAF patients develop persistent atrial fibrillation.
  • The predictive role of soluble ST2 (sST2) for POAF onset is not well-established.

Purpose of the Study:

  • To investigate the association between preoperative sST2 levels and the incidence of POAF.
  • To determine if sST2 can predict POAF development in patients undergoing elective cardiac surgery.
  • To explore the relationship between sST2 levels and POAF duration.

Main Methods:

  • Preoperative sST2 levels were measured in 496 patients without a history of AF undergoing elective cardiac surgery.
  • Patients included those having valve, coronary artery bypass graft, or combined procedures.
  • Statistical analyses, including logistic regression and linear regression, were used to assess the predictive value of sST2.

Main Results:

  • 42.3% of patients developed POAF.
  • Preoperative sST2 levels were significantly higher in patients who developed POAF.
  • sST2 predicted POAF in women (OR 1.894) but not in men (OR 1.091).
  • Each 1 ng/mL increase in sST2 correlated with an additional 39.5 minutes of POAF duration.

Conclusions:

  • Preoperative sST2 levels can predict the onset of POAF in women undergoing cardiac surgery.
  • sST2 levels are associated with the overall burden (duration) of POAF.
  • Incorporating sST2 assessment with existing risk factors may enhance POAF risk stratification.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...